Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.51 USD | +0.45% | -5.65% | +72.80% |
May. 07 | Citigroup Starts Summit Therapeutics With Buy Rating, $7 Price Target | MT |
May. 01 | Transcript : Summit Therapeutics Inc., Q1 2024 Earnings Call, May 01, 2024 |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 2.5B 3.16B |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 105 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 11.86% |
Latest transcript on Summit Therapeutics Inc.
1 day | +0.45% | ||
1 week | -5.65% | ||
Current month | +14.76% | ||
1 month | +27.40% | ||
3 months | -11.05% | ||
6 months | +142.47% | ||
Current year | +72.80% |
Managers | Title | Age | Since |
---|---|---|---|
Mahkam Zanganeh
CEO | Chief Executive Officer | 52 | 20-11-10 |
Robert Duggan
CEO | Chief Executive Officer | 79 | 19-11-30 |
Director of Finance/CFO | 46 | 19-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Duggan
CEO | Chief Executive Officer | 79 | 19-11-30 |
Robert Booth
BRD | Director/Board Member | 70 | 22-09-27 |
Director of Finance/CFO | 46 | 19-11-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.00% | 34 M€ | +4.26% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 4.51 | +0.45% | 1,323,617 |
24-05-15 | 4.49 | -4.16% | 1,836,454 |
24-05-14 | 4.685 | -2.40% | 1,667,094 |
24-05-13 | 4.8 | +3.23% | 2,065,715 |
24-05-10 | 4.65 | -2.72% | 1,781,959 |
Delayed Quote Nasdaq, May 16, 2024 at 04:00 pm EDT
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+72.80% | 3.17B | |
+8.29% | 114B | |
+10.21% | 104B | |
+0.41% | 22.28B | |
-11.90% | 22.41B | |
-5.99% | 19.07B | |
-37.36% | 18B | |
-5.17% | 17.89B | |
+7.70% | 14.28B | |
+37.65% | 12.55B |
- Stock Market
- Equities
- SMMT Stock